Not Otherwise Specified Diffuse Large B-cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-08-24
Clinical Trial Update: JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating JCAR014 in combination with Durvalumab for relapsed or refractory B-cell non-Hodgkin lymphoma has been terminated; …